Dr Sheena McCormack (MRC Clinical Trials Unit at UCL) says
that users of Truvada, anti-retroviral drug that can be used to cut the risk of
HIV infection, are making highly nuanced decisions about their risks.
Read: New
Scientist,
More: Herald Scotland
Close
